(10), CH3 (11). The synthesis of 1-11 was accomplished by reductive coupling of the corresponding 2-phenyl-2-propanols with TiCl3 and LiAlH4. The binding affinity of the compounds to the calf uterine estrogen receptor was measured relative to that of [3H]estradiol by a competitive binding assay. With the exception of 7 and 10 all other compounds showed relative binding affinity (RBA) values between
1,1,2,2-四甲基-1,2-双(
4-羟苯基)
乙烷(1)和5,5'-和6,6'-的对称2,2'-二取代衍
生物的合成描述了1,1,2,2-四甲基-1,2-双(3-羟基苯基)
乙烷的双取代衍
生物(6)(1和6是具有抑制乳腺肿瘤活性的强抗
雌激素药物,仅表现出轻微的
雌激素特性):(2 ,2'-取代基)F(2),Cl(3),O (4),
CH3(5); (5,5'-取代基)Cl(7); (6,6'-取代基)F(8),Cl(9),O (10), (11)。1-11的合成通过相应的
2-苯基-2-丙醇与TiCl3和LiAlH4的还原偶联而完成。通过竞争性结合测定法,相对于[3 H]
雌二醇,测定化合物对小牛子宫
雌激素受体的结合亲和力。除7和10外,所有其他化合物的相对结合亲和力(RBA)值在
雌二醇,2(RBA值6.4),8和9(4.0和3.5)的相对亲和力(0.5%)至6.4%之间,超过了相应的未取代化合物1和6(3